ICBMT 2025

Program at a Glance

Day 2: Sep. 12 (Fri)

Room A (1F) Room B (1F) Room C (2F) Room D (2F)
08:30-09:00 Satellite Symposium 1 Satellite Symposium 2
09:00-10:00 Oral 5 Oral 6 Oral 7 Oral 8
10:00-10:10 Break
10:10-11:40 Joint Symposium 3
(East Asia Collaborative Session)
Scientific Session 5
(KAICET-Cell Therapy Committee Joint Session)
Scientific Session 6 Education Session 2
Stem Cell Transplantation in Diffuse Large B-cell Lymphoma in the Era of Immunotherapy Next-Generation Immune Cell Therapies: From Design to Clinical Application GVHD Update: Evolving Paradigms in Diagnosis and Therapy Smart research Practices: From data analysis to writing
11:40-11:50
11:50-12:00 Break
12:00-12:40 Luncheon Symposium 5 Luncheon Symposium 6 Luncheon Symposium 7 Luncheon Symposium 8
12:40-13:00 Break
13:00-14:30 Scientific Session 7 Scientific Session 8 Nursing Session 1

Kor

Education Session 3
Transplantation and Relapse: Evidence and Practice Updates Advances in Pediatric Transplantation and Cellular Therapy Multidisciplinary Approach to Treatment after Hematopoietic Stem Cell Transplantation l Optimizing Outcomes in HSCT
14:30-14:40 Break
14:40-15:20 Presidential Symposium
AML-Specific Therapeutics: Integrating Risk-Stratified Transplantation and Immunotherapeutic Targeting
15:20-16:00 Plenary Session 3
Personalized Conditioning Strategies in Allogeneic HSCT: Balancing Disease Control and Toxicity Across Age Groups
16:00-16:10 Break
16:10-16:30 Poster
16:30-16:40 Break
16:40-18:10 Debate Session 1 & 2

Kor
*The session will feature AI-powered real-time English subtitles and audience voting.

Joint Symposium 4
(JSTCT-KSBMT)
Education Session 4
[DS01] Splenectomy Prior to HSCT in Myelofibrosis: Necessity or Risk?
[DS02] Donor Selection for HSCT in Pediatric Leukemia: Haploidentical versus Other Alternative Donor
Transplant Strategies to overcome MRD positive hematologic malignancies Infectious Complication
18:10-18:20
18:45~ Gala Dinner